eTheRNA immunotherapies NV, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, announced the opening of its new subsidiary, eTheRNA Asia Limited (‘eTheRNA Asia’), with offices located in the Sheung Wan area of Hong Kong.